Contributors

Aaron Lapat

Managing Partner
Bruce Rychlik

Managing Partner, Life Sciences
Erik Lundh

Managing Partner
Jesse Hershman

Partner
Jonathan Fortescue

Managing Partner
Park Square Executive Search
Stacey Lerner

Partner

Park Square Executive Search Archive

Elutia Selects Pete Ligotti as CCO to Lead the Commercial Launch of NXT-41x and Transform Post-Mastectomy Care in the $1.5B U.S. Breast Surgery Market

Park Square Executive Search

3/2/2026 3:17:00 PM

https://www.passle.net/Content/Images/passle_logo-186px.png Passle https://passle.net

Park Square Executive Search

Park Square has placed Pete Ligotti as Chief Commercial Officer at Elutia.

Elutia Inc. (Nasdaq: ELUT) ("Elutia" or the "Company"), a pioneer in drug-eluting biomatrix technologies, today announced the appointment of Pete Ligotti as Chief Commercial Officer.

https://investors.elutia.com/news-releases/news-release-details/elutia-selects-pete-ligotti-cco-lead-commercial-launch-nxt-41x

unknownx500

More posts by Park Square Executive Search

Park Square Announces Ashley Finney as Partner in Life Sciences Practice

Park Square Announces Ashley Finney as Partner in Life Sciences Practice

Park Square Executive Search

Generate:Biomedicines Welcomes Aarif Khakoo, MD, MBA, as Chief Scientific Officer

Generate:Biomedicines Welcomes Aarif Khakoo, MD, MBA, as Chief Scientific Officer

Park Square Executive Search

CEO Interview Series: Team Building in Private Equity-backed SaaS Companies

CEO Interview Series: Team Building in Private Equity-backed SaaS Companies

Park Square Executive Search

Park Square Places Ben Sebree as Chief Product and Technology Officer and Bob Tenzillo as Chief Revenue Officer at three+one

Park Square Places Ben Sebree as Chief Product and Technology Officer and Bob Tenzillo as Chief Revenue Officer at three+one

Park Square Executive Search

Park Square Announces New Partner, Bob Huseby

Park Square Announces New Partner, Bob Huseby

Park Square Executive Search

Recent posts from Park Square Executive Search

What are you listening to?

What are you listening to?

Aaron Lapat

Life Sciences Quarterly Newsletter from Park Square Executive Search

Life Sciences Quarterly Newsletter from Park Square Executive Search

Erik Lundh

Time to update the list...

Time to update the list...

Aaron Lapat

Deep Genomics Announces the Appointment of Brian O'Callaghan as CEO

Deep Genomics Announces the Appointment of Brian O'Callaghan as CEO

Erik Lundh

Dr. Laura Carter joins Character Biosciences as CSO

Dr. Laura Carter joins Character Biosciences as CSO

Erik Lundh

repost cancel

As a free user, you can like posts.

To repost this post to your own Passle blog, you will need to upgrade your account.

For plans and pricing, please contact our sales team at sales@passle.net

Sorry, you don't have permission to repost or create posts.

cancel